CN1247252C - Blood stasis eliminating powder - Google Patents

Blood stasis eliminating powder Download PDF

Info

Publication number
CN1247252C
CN1247252C CN 200310109703 CN200310109703A CN1247252C CN 1247252 C CN1247252 C CN 1247252C CN 200310109703 CN200310109703 CN 200310109703 CN 200310109703 A CN200310109703 A CN 200310109703A CN 1247252 C CN1247252 C CN 1247252C
Authority
CN
China
Prior art keywords
cloth
powder
blood stasis
paste
dispersing blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200310109703
Other languages
Chinese (zh)
Other versions
CN1546092A (en
Inventor
张一欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200310109703 priority Critical patent/CN1247252C/en
Publication of CN1546092A publication Critical patent/CN1546092A/en
Application granted granted Critical
Publication of CN1247252C publication Critical patent/CN1247252C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to powder for dispersing blood stasis, which belongs to a traditional Chinese medicine for treating human parenchyma contusion caused by traumatic injuries. The present invention has the main technical feature that the powder for dispersing blood stasis is prepared from the following raw materials of parts by weight: 1 portion of common prism tuber, 1 portion of zedoray and 1 portion of cape jasmine fruit, is prepared by processes of pulverizing the three medicines into fine powder and uniformly confecting the fine powder with egg white into paste, and is used by spreading out the paste on white cloth, applying the white cloth to afflicted parts, coating the white cloth with a plastic film and wrapping the white cloth well. The present invention has the advantages of rapid therapeutic effect and obvious effect on the treatment for traumatic injures. Because of the main symptoms of reddish swelling and thermalgesia of afflicated parts caused by traumatic injuries, the powder for dispersing blood stasis can have obvious therapeutic effects after 1 to 2 days when used by patients. Besides, because the powder for dispersing blood stasis is used by confecting the medicines into paste, spreading out the confected medicines on cloth, applying the cloth to afflicted parts, coating the cloth with a plastic film and wrapping the cloth well, the volatilization of medicine properties is reduced; thereby, the present invention has the advantages of long endurance time of therapeutic effects, long acting time of medicine efficiency and obvious therapeutic effect, and injury conditions can be cured within 2 to 3 days generally.

Description

Powder for dispersing blood stasis
One, technical field
The invention belongs to the Chinese medicine that treatment causes human body soft tissue to be dampened because of traumatic injury.
Two, background technology
People in daily life, and are normal injured because of human body soft tissue takes place accidentally, sprain as foot when going downstairs, and because of the contingency knee of damaging, hip joint is impaired, or soft tissue is pulled etc.Therapeutic Method commonly used is: rub the affected part with the safflower oil traumatic, pill for traumatic injuries for oral administration in addition, antibiotic medicine etc.The safflower oil medicine belongs to volatile liquid, be applied in the affected part after, most of medicinal liquid volatilizees in air, the absorbtivity in affected part is less; While is meeting injured skin top layer in smearing the process of rubbing, and oral medicine takes effect also slower.
Three, summary of the invention
The purpose of this invention is to provide a kind of treatment traumatic injury, the powder for dispersing blood stasis that human body soft tissue baffles, the course of treatment is fast, and good effect has no side effect.
Powder for dispersing blood stasis is equipped with by following raw material and weight portion:
1 part of rhizoma sparganic, 1 part of Rhizoma Curcumae, 1 part of Fructus Gardeniae;
Elder generation is broken into fine powder with above-mentioned three kinds of medicated powder, mixes well with Ovum Gallus domesticus album to be paste, is spread out on the calico again, spreads on the affected part, covers with plastic sheeting, wraps up.
Pharmacology analysis:
Rhizoma sparganic, Rhizoma Curcumae are monarch drug, and wherein rhizoma sparganic is bitter puts down slack falling, but removing blood stasis, promoting the circulation of QI to relieve pain are gone into liver spleen blood system, and the efficacy of a drug is higher, the pain relieving of energy circulation of qi promoting removing food stagnancy;
The Rhizoma Curcumae suffering is loose, and it is logical that hardship is let out temperature, goes into the liver spleen and divides gas, high kind the cutting of property, the blood in the energy dispelling the stagnated QI;
The two is the product of removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving rhizoma sparganic, Rhizoma Curcumae, so all QI and blood block the long-pending disease of tangible heavily fortified point, and the use that also often matches of two medicines.Though two medicines are difference to some extent on effect, because of QI and blood connects each other, controlling blood must first circulation of qi promoting, and the capable then blood of gas is capable, and then curative effect is better so the two is with usefulness.
The Fructus Gardeniae bitter cold is gone into the heart, liver, lung, stomach, and tri-jiao channel is the ministerial drug of rhizoma sparganic, Rhizoma Curcumae, cooling blood and relieving pain.
The beneficial effect that uses the present invention to treat traumatic injury is, curative effect is fast, and effect is remarkable, and after traumatic injury, affected part has the red and swollen heat pain symptom mostly, use powder for dispersing blood stasis after the patient obvious curative effects was just arranged after 1-2 days.
Because powder for dispersing blood stasis is modulated into paste and is spread out in and spreads on the affected part on the cloth, cover the back with plastic sheeting in addition and wrap up, reduced property of medicine volatilization, thus curative effect time continue, efficacy of a drug long action time, instant effect generally can be cured in condition of the injury 2-3 days.
Select traumatic injury patient 100 examples as object of study, sprain of foot person 32 examples wherein, sprain of wrist person 7 examples, knee joint bumps the wounded's 21 examples, and hip joint falls the wounded's 15 examples, and foot is pounded the wounded's 9 examples, soft tissue draws the wounded's 6 examples, neonate scalp hematoma 2 examples, neonate scalp edema 8 examples, pain relieving in 2-3 hour after the drug of topical application, changed a medicine in 8-10 hour, 90% patient 2-3 day was almost recovered, and 6% patient 5-6 day fully recovered, and all the other heavier patient 8-10 days cure.
Four, the specific embodiment
With rhizoma sparganic, Rhizoma Curcumae, each parts by weight of Fructus Gardeniae, be crushed to fine powder earlier, the reuse Ovum Gallus domesticus album transfers to paste, and use amount is decided on the affected part size.Poultice is spread out in spreads on the affected part on the calico, cover with plastic sheeting at last, wrap, become dry to prevent ointment with bundle.

Claims (1)

1, powder for dispersing blood stasis is characterized in that:
A, be equipped with: 1 part of rhizoma sparganic, 1 part of Rhizoma Curcumae, 1 part of Fructus Gardeniae by following raw material and weight portion;
B, elder generation are broken into fine powder with above-mentioned three kinds of Chinese medicine powders, and the reuse Ovum Gallus domesticus album is mixed well and is paste, is spread out on the calico.
CN 200310109703 2003-12-12 2003-12-12 Blood stasis eliminating powder Expired - Fee Related CN1247252C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200310109703 CN1247252C (en) 2003-12-12 2003-12-12 Blood stasis eliminating powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200310109703 CN1247252C (en) 2003-12-12 2003-12-12 Blood stasis eliminating powder

Publications (2)

Publication Number Publication Date
CN1546092A CN1546092A (en) 2004-11-17
CN1247252C true CN1247252C (en) 2006-03-29

Family

ID=34335357

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200310109703 Expired - Fee Related CN1247252C (en) 2003-12-12 2003-12-12 Blood stasis eliminating powder

Country Status (1)

Country Link
CN (1) CN1247252C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103751342B (en) * 2014-02-14 2016-01-27 刘维忠 A kind of medicine with heat-clearing and toxic substances removing, reducing swelling and alleviating pain function
CN104189722B (en) * 2014-07-20 2017-10-31 王兴超 One kind treats traumatic injury liquid medicine of exterior coating

Also Published As

Publication number Publication date
CN1546092A (en) 2004-11-17

Similar Documents

Publication Publication Date Title
CN1255172C (en) Medical paste for rheumatism and bone ache
CN1634225A (en) Medicine for reducing swelling, easing pain, promoting bone reunion and the preparation process thereof
CN101234153B (en) Externally-applied medicament for treating bone fracture
CN100534480C (en) Bone-setting medicine and preparation method thereof
CN101850092A (en) Medicament for treating trauma and preparation method thereof
CN1247252C (en) Blood stasis eliminating powder
CN1046420C (en) Prescription for external use medicine for curing many kinds of diseases
CN1454660A (en) Bone-setting medicine
CN1080122C (en) Medicine for injury pain and its preparation
CN103638116B (en) The auxiliary natural herbal mixture of a kind of synthetism
CN1073100A (en) Multifunction specific ointment
CN1255143C (en) Externally applied Chinese traditional medicinal wine and its preparing method
CN1994380B (en) Externally applied medicine for treating arthritis, hot pack and preparation method thereof
CN109966451A (en) A kind of Chinese medicine composition of bone-setting and pain-relieving
CN1814080A (en) External-use medicine for treating protrusion of intervertebral disc and hyperosteoguey
CN110090286A (en) A kind of production method of plaster, plaster and plaster and plaster
CN1127966C (en) 'Hehe' ointment and its preparing process
CN1112212C (en) Medicine liquid for treating pain of injury
CN101129542A (en) Pill for relieving pain of windchill
RU2182490C1 (en) Composition of biostimulating and antitoxic action
CN1233335C (en) Exterior-applied liquid medicine for treating skin itching and its preparing process
CN1973893A (en) Externally applied medicine for treating neck and waist arthrosis
CN1051461C (en) Medicine-Zhengxie San and its preparation
CN1245190C (en) Hemiplegia hypertension and contraceptive treating plaster
CN1245181C (en) Chinese medicine of capsule (tablet) of nine ingredients for treating psoriasis and its preparing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060329

Termination date: 20100112